4) Technical and Professional Questions (the real separator)
This is where interviews stop being polite and start being real. A strong Pharmacy Technician candidate in Canada can talk through workflows: controlled substances, third-party billing, compounding basics, and the pharmacy management system. If you’ve used Kroll, say so. If you haven’t, show you understand what these systems control—patient profiles, adjudication, audit trails—and how you work safely when the system is slow or down.
Q: Walk me through your end-to-end dispensing workflow—from receiving the prescription to release.
Why they ask it: They want to hear a safe, repeatable process with built-in checks.
Answer framework: Stepwise workflow + “control points.” Mention identity verification, data entry checks, product selection, labeling, documentation, and pharmacist check.
Example answer: “I start by confirming patient identifiers and scanning/attaching the Rx image so the record is complete. During data entry I verify drug, strength, dosage form, directions, quantity, refills, prescriber details, and any notes—then I cross-check against the patient profile for prior therapy patterns. In filling, I select the correct DIN/brand as required, count or measure using clean technique, and label with auxiliary labels as appropriate. I barcode-scan where available and keep one Rx in my workspace at a time. Before release, I ensure the pharmacist has completed the required check and that pickup identity is confirmed and documented.”
Common mistake: Skipping documentation/audit trail steps and focusing only on counting pills.
Q: Which pharmacy systems have you used (e.g., Kroll), and what tasks did you perform in them?
Why they ask it: System fluency affects speed, accuracy, and billing outcomes.
Answer framework: Tool–Task–Outcome. Name the system(s), your daily tasks, and one measurable impact (fewer rejections, faster turnaround).
Example answer: “I’ve used Kroll for patient profile management, Rx entry, refills, third-party adjudication, and generating reports for inventory and controlled drugs. I’m comfortable with attaching Rx images, adding clinical notes for the pharmacist, and troubleshooting common claim rejections like days’ supply or DIN mismatches. In my last role, I reduced rework by standardizing how we entered directions and days’ supply for chronic meds, which cut adjudication reversals during peak hours.”
Common mistake: Saying “I used the system” without specifying what you actually did inside it.
Q: How do you handle third-party billing rejections and reversals?
Why they ask it: Billing errors create patient conflict, compliance risk, and lost revenue.
Answer framework: Triage–Fix–Document–Escalate. Show you know when to fix, when to call, and when to involve the pharmacist.
Example answer: “I start by reading the rejection code and checking the basics: patient coverage details, DIN, quantity, days’ supply, and whether it’s too soon. If it’s a data issue, I correct it and re-adjudicate, documenting what changed. If it’s clinical—like a therapeutic duplication message—or needs an override, I involve the pharmacist. For persistent payer issues, I follow our process for calling the help desk and documenting the call reference.”
Common mistake: Blaming the insurer without showing a systematic troubleshooting approach.
Q: What’s your process for controlled substances: receiving, storage, dispensing, and reconciliation?
Why they ask it: Controlled drugs are high-risk and heavily audited.
Answer framework: Chain-of-custody narrative. Mention secure storage, perpetual inventory where used, witnessed counts, discrepancy escalation.
Example answer: “I treat controlled substances as a chain-of-custody workflow. On receiving, I verify the invoice against what arrived, document according to policy, and store immediately in the secure area. During dispensing, I follow the required documentation and double-check counts, especially for partial fills. For reconciliation, I do scheduled counts, investigate discrepancies by checking transaction logs and recent fills, and escalate immediately to the pharmacist-in-charge if anything doesn’t reconcile. The key is documenting every step so an audit trail exists.”
Common mistake: Talking about controlled drugs like regular stock.
Q: How do you apply NAPRA standards or provincial college expectations in daily work?
Why they ask it: They want to see you understand that Canadian pharmacy practice is standards-driven.
Answer framework: Standard–Behavior–Example. Name a standard area (documentation, compounding, quality assurance) and how it changes your behavior.
Example answer: “I use NAPRA guidance as the baseline for safe technical practice—especially around documentation, quality assurance, and compounding expectations. Practically, that means I keep clean, complete records, follow validated procedures instead of improvising, and treat near-misses as something to document and learn from. In my last role, we used a simple QA checklist for high-risk fills and it reduced rework and pharmacist callbacks.”
Common mistake: Name-dropping NAPRA without connecting it to concrete daily actions.
Q: Explain how you calculate days’ supply and why it matters for adjudication and safety.
Why they ask it: Days’ supply errors drive claim rejections and can cause early/late refills.
Answer framework: Formula + edge cases. Give one straightforward example and one tricky one (tapers, PRN, insulin, inhalers).
Example answer: “For tablets it’s usually quantity divided by daily dose, but I always sanity-check against the directions. If it’s ‘1–2 tablets twice daily PRN,’ I clarify how the pharmacy wants to calculate and document the assumption because it affects refill timing. For inhalers or insulin, I use the device’s total doses/volume and the prescribed daily use to calculate a defensible days’ supply. Getting it right prevents both payer issues and unsafe early refills.”
Common mistake: Guessing days’ supply to ‘make the claim go through.’
Q: What’s your approach to high-alert medications (e.g., methotrexate weekly dosing, insulin, anticoagulants)?
Why they ask it: These are common, high-harm error categories.
Answer framework: Identify–Pause–Verify–Flag. Show you recognize red flags and build in extra checks.
Example answer: “For high-alert meds, I slow down on purpose. If I see methotrexate, I immediately check that directions are weekly, confirm the quantity aligns, and flag it for pharmacist attention if anything looks daily. For insulin or anticoagulants, I verify strength, device type, and directions carefully and ensure notes are clear for counseling. My goal is to prevent the classic errors—wrong frequency, wrong strength, wrong device.”
Common mistake: Treating high-alert meds like routine refills.
Q: Describe your experience with compounding (non-sterile or sterile) and the documentation you follow.
Why they ask it: Compounding requires procedure discipline and traceability.
Answer framework: Scope–Procedure–Record. Be honest about what you’ve done; emphasize following master formulas, lot tracking, BUD, and cleaning.
Example answer: “My experience is mainly non-sterile compounding—creams and oral suspensions—following a master formulation record and documenting lot numbers, quantities, and beyond-use dates. I’m strict about weighing/measuring accuracy, cleaning between preparations, and labeling requirements. If the role includes sterile compounding, I’m ready to train into it and I understand the expectation is validated technique and complete documentation, not ‘learning as you go’ on live product.”
Common mistake: Overselling sterile compounding experience when you’ve only observed it.
Q: How do you manage inventory to prevent shortages and expired stock—especially for fast movers and cold chain items?
Why they ask it: Inventory discipline affects patient care and cost.
Answer framework: Forecast–Rotate–Monitor. Mention FEFO (first-expire-first-out), fridge logs, and ordering patterns.
Example answer: “I manage inventory with a mix of routine and alerts: FEFO rotation during put-away, regular expiry checks, and watching fast movers so we don’t hit zero unexpectedly. For cold chain, I follow temperature log procedures and minimize door-open time during receiving. When something is backordered, I document alternatives and communicate early so the pharmacist can plan therapeutic options if needed.”
Common mistake: Saying you ‘just order when it looks low.’
Q: What would you do if the pharmacy system (e.g., Kroll) goes down during a rush?
Why they ask it: Downtime happens; they want safe continuity, not chaos.
Answer framework: Safety-first downtime protocol. Cover: switch to downtime forms, protect PHI, manual documentation, reconcile later.
Example answer: “First I’d confirm it’s a true outage and notify the pharmacist/manager so we switch to the downtime process. We’d prioritize urgent meds, use approved manual documentation to capture patient identifiers, drug details, quantities, and prescriber info, and keep paperwork secured to protect PHI. I’d avoid ‘memory-based’ refills and ensure any controlled substances follow the strictest documentation. Once systems are back, I’d reconcile entries carefully so the electronic record matches what was dispensed.”
Common mistake: Trying to keep dispensing normally without an audit trail.
Q: How do you handle a prescription that looks technically correct but clinically questionable?
Why they ask it: They want you to recognize red flags and escalate appropriately.
Answer framework: Observe–Verify facts–Escalate. Stay in technician lane but show strong judgment about when to pause.
Example answer: “If it’s clinically questionable—like an unusually high dose, duplicate therapy, or a dangerous interaction flag—I don’t try to solve it myself. I verify the facts: what’s written, what’s in the patient profile, and what the system flags. Then I bring it to the pharmacist with a clear summary and I pause the workflow until they assess and decide next steps.”
Common mistake: Either ignoring the red flag or trying to make a clinical decision yourself.